We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-0.26%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$668M
AUM Growth
-$130M
Cap. Flow
-$43.4M
Cap. Flow %
-6.5%
Top 10 Hldgs %
87.83%
Holding
33
New
11
Increased
4
Reduced
10
Closed
5

Top Buys

Rank Stock Value
1
VIR icon
Vir Biotechnology
VIR
+$24.3M
2
DMTK
DermTech, Inc. Common Stock
DMTK
+$13.8M
3
CDAK
Codiak BioSciences, Inc. Common Stock
CDAK
+$11.9M
4
CAPR icon
Capricor Therapeutics
CAPR
+$11.5M
5
YMAB
Y-mAbs Therapeutics
YMAB
+$10.4M

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$124M
2
PACB icon
Pacific Biosciences
PACB
+$9.63M
3
AGEN
Agenus
AGEN
+$9.13M
4
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$6.32M
5
SLNO
Soleno Therapeutics
SLNO
+$3.31M

Sector Composition

Rank Sector Weight
1 Healthcare 99.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$145M 21.73%
2,123,271
-25,000
-1% -$2.02M
QDEL icon
2
QuidelOrtho
QDEL
$1.14B
$139M 20.89%
1,090,309
-669,112
-38% -$124M
AWH
3
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$58.4M 8.74%
576,473
– –
OPK icon
4
Opko Health
OPK
$1.25B
$55M 8.24%
12,821,273
-350,000
-3% -$1.67M
PACB icon
5
Pacific Biosciences
PACB
$432M
$48.2M 7.22%
1,446,459
-275,000
-16% -$9.63M
DMTK
6
DELISTED
DermTech, Inc. Common Stock
DMTK
$36.2M 5.43%
713,577
+263,577
+59% +$13.8M
AXDX
7
DELISTED
Accelerate Diagnostics
AXDX
$31.4M 4.7%
377,612
-3,002
-0.8% -$305K
AGEN
8
Agenus
AGEN
$275M
$25.5M 3.82%
477,584
-126,294
-21% -$9.13M
BCRX icon
9
BioCryst Pharmaceuticals
BCRX
$2.48B
$24.1M 3.61%
2,367,670
-613,200
-21% -$6.32M
VIR icon
10
Vir Biotechnology
VIR
$1.49B
$23.1M 3.46%
+450,331
New +$24.3M
AMRN
11
Amarin Corp
AMRN
$293M
$12.9M 1.94%
104,242
+52,603
+102% +$7.07M
YMAB
12
DELISTED
Y-mAbs Therapeutics
YMAB
$11.5M 1.72%
380,642
+254,300
+201% +$10.4M
CAPR icon
13
Capricor Therapeutics
CAPR
$380M
$9.36M 1.4%
+1,999,464
New +$11.5M
CDAK
14
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$8.22M 1.23%
+545,360
New +$11.9M
ATRS
15
DELISTED
Antares Pharma, Inc.
ATRS
$7.81M 1.17%
1,900,000
– –
SEM
16
DELISTED
Select Medical
SEM
$7.67M 1.15%
+417,600
New +$6.85M
CFRX
17
DELISTED
ContraFect Corporation
CFRX
$7.45M 1.12%
19,405
+17,310
+826% +$7.47M
BDSX icon
18
Biodesix
BDSX
$218M
$4.78M 0.72%
11,776
– –
MOTS
19
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$4.54M 0.68%
12,492
-197
-2% -$85.9K
SLNO
20
DELISTED
Soleno Therapeutics
SLNO
$2.69M 0.4%
142,133
-102,559
-42% -$3.31M
FORA
21
DELISTED
Forian
FORA
$1.57M 0.24%
+155,440
New +$1.99M
BIIB icon
22
Biogen
BIIB
$30.4B
$675K 0.1%
2,412
-1,276
-35% -$344K
SEM
23
PUT
DELISTED
Select Medical
SEM
$585K 0.09%
+185,600
New +$3.04M
PACB icon
24
PUT
Pacific Biosciences
PACB
$432M
$505K 0.08%
+100,000
New +$3.5M
QDEL icon
25
PUT
QuidelOrtho
QDEL
$1.14B
$363K 0.05%
+50,000
New +$9.23M
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Oracle Investment Management held 33 positions worth $668M, down 16% from $798M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Oracle Investment Management withdrew a net $43.4M in Q1 2021, closing 5 positions and reducing 10 holdings. Its most notable exit was Translate Bio, Inc. Common Stock, an estimated $1.84M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier.

Against the trend, Oracle Investment Management opened a new position in Vir Biotechnology worth $23.1M.

  • Oracle Investment Management's largest Q1 2021 buy was Vir Biotechnology: 450,331 shares worth $23.1M.
  • Oracle Investment Management added most to DermTech, Inc. Common Stock in Q1 2021, an estimated $13.8M increase.
  • Oracle Investment Management's biggest Q1 2021 reduction was QuidelOrtho, cutting an estimated $124M.
  • Oracle Investment Management fully exited Translate Bio, Inc. Common Stock in Q1 2021, selling an estimated $1.84M.
  • Oracle Investment Management's ten largest holdings make up 88% of its $668M portfolio in Q1 2021.
  • Oracle Investment Management opened 11 new positions and closed 5 in Q1 2021.
  • Oracle Investment Management's portfolio value fell 16% quarter-over-quarter to $668M.

Based on Oracle Investment Management's 13F filing for Q1 2021, filed 17 May 2021.